Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
methylprednisolonacetatpræparat til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Methylprednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Methylprednisolone acetate 40mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Methylprednisolone acetate 80mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Methylprednisolone acetate 40mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Methylprednisolone acetate 40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 40 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
|
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Methylprednisolone acetate 40 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Methylprednisolone acetate 40 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone acetate |
Inferred relationship |
Some |
2 |